Ganapathi Asvin M, Mulvihill Michael S, Englum Brian R, Speicher Paul J, Gulack Brian C, Osho Asishana A, Yerokun Babatunde A, Snyder Laurie R, Davis Duane, Hartwig Matthew G
Department of Surgery, Duke University Medical Center, Durham, NC, USA.
Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Transpl Int. 2017 Apr;30(4):378-387. doi: 10.1111/tri.12913.
To maximize the benefit of lung transplantation, the effect of size mismatch on survival in lung transplant recipients with restrictive lung disease (RLD) was examined. All single and bilateral RLD lung transplants from 1987 to 2011 in the United Network for Organ Sharing (UNOS) Database were identified. Donor predicted total lung capacity (pTLC):Recipient pTLC ratio (pTLCr) quantified mismatch. pTLCr was segregated into five strata. A Cox proportional hazards model evaluated the association of pTLCr with mortality hazard. To identify a critical pTLCr, a Cox model using a restricted cubic spline for pTLCr was used. A total of 6656 transplants for RLD were identified. Median pTLCr for single orthotopic lung transplant (SOLT) and bilateral orthotopic lung transplant (BOLT) was 1.0 (0.69-1.47) and 0.98 (0.66-1.45). Examination of pTLCr as a categorical variable revealed that undersizing (pTLCr <0.8) for SOLT and moderate oversizing (pTLCr = 1.1-1.2) for SOLT and BOLT had a harmful survival effect [for SOLT pTLC <0.8: HR 1.711 (95% CI 1.146-2.557), P = 0.01 and for BOLT pTLC 1.1-1.2: HR 1.717 (95% CI 1.112-2.651), P = 0.02]. Spline analysis revealed significant changes in SOLT mortality by variation of pTLCr between 0.8-0.9 and 1.1-1.2. RLD patients undergoing SOLT are susceptible to detriments of an undersized lung. RLD patients undergoing BOLT have higher risk of mortality when pTLCr falls between 1.1 and 1.2.
为了使肺移植的益处最大化,研究了大小不匹配对限制性肺病(RLD)肺移植受者生存的影响。确定了1987年至2011年器官共享联合网络(UNOS)数据库中所有单肺和双肺RLD肺移植病例。供体预测总肺容量(pTLC)与受者pTLC之比(pTLCr)用于量化不匹配情况。pTLCr被分为五个层次。采用Cox比例风险模型评估pTLCr与死亡风险的关联。为了确定关键的pTLCr,使用了一个对pTLCr采用受限立方样条的Cox模型。共确定了6656例RLD移植病例。单肺原位移植(SOLT)和双肺原位移植(BOLT)的pTLCr中位数分别为1.0(0.69 - 1.47)和0.98(0.66 - 1.45)。将pTLCr作为分类变量进行分析发现,SOLT的肺过小(pTLCr <0.8)以及SOLT和BOLT的适度肺过大(pTLCr = 1.1 - 1.2)对生存有有害影响[对于SOLT,pTLC <0.8:风险比(HR)1.711(95%置信区间1.146 - 2.557),P = 0.01;对于BOLT,pTLC 1.1 - 1.2:HR 1.717(95%置信区间1.112 - 2.651),P = 0.02]。样条分析显示,当pTLCr在0.8 - 0.9和1.1 - 1.2之间变化时,SOLT死亡率有显著变化。接受SOLT的RLD患者易受肺过小的损害。当pTLCr在1.1和1.2之间时,接受BOLT的RLD患者死亡风险更高。